These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
186 related items for PubMed ID: 8558511
1. Characterizations of the unusual dissociation properties of melanotropin peptides from the melanocortin receptor, hMC1R. Haskell-Luevano C, Miwa H, Dickinson C, Hadley ME, Hruby VJ, Yamada T, Gantz I. J Med Chem; 1996 Jan 19; 39(2):432-5. PubMed ID: 8558511 [Abstract] [Full Text] [Related]
2. Biological and conformational examination of stereochemical modifications using the template melanotropin peptide, Ac-Nle-c[Asp-His-Phe-Arg-Trp-Ala-Lys]-NH2, on human melanocortin receptors. Haskell-Luevano C, Nikiforovich G, Sharma SD, Yang YK, Dickinson C, Hruby VJ, Gantz I. J Med Chem; 1997 May 23; 40(11):1738-48. PubMed ID: 9171884 [Abstract] [Full Text] [Related]
3. Three-dimensional molecular models of the hMC1R melanocortin receptor: complexes with melanotropin peptide agonists. Haskell-Luevano C, Sawyer TK, Trumpp-Kallmeyer S, Bikker JA, Humblet C, Gantz I, Hruby VJ. Drug Des Discov; 1996 Dec 23; 14(3):197-211. PubMed ID: 9017363 [Abstract] [Full Text] [Related]
4. Cyclic lactam alpha-melanotropin analogues of Ac-Nle4-cyclo[Asp5, D-Phe7,Lys10] alpha-melanocyte-stimulating hormone-(4-10)-NH2 with bulky aromatic amino acids at position 7 show high antagonist potency and selectivity at specific melanocortin receptors. Hruby VJ, Lu D, Sharma SD, Castrucci AL, Kesterson RA, al-Obeidi FA, Hadley ME, Cone RD. J Med Chem; 1995 Sep 01; 38(18):3454-61. PubMed ID: 7658432 [Abstract] [Full Text] [Related]
5. Discovery of prototype peptidomimetic agonists at the human melanocortin receptors MC1R and MC4R. Haskell-Luevano C, Hendrata S, North C, Sawyer TK, Hadley ME, Hruby VJ, Dickinson C, Gantz I. J Med Chem; 1997 Jul 04; 40(14):2133-9. PubMed ID: 9216831 [Abstract] [Full Text] [Related]
6. Potent and prolonged acting cyclic lactam analogues of alpha-melanotropin: design based on molecular dynamics. Al-Obeidi F, Castrucci AM, Hadley ME, Hruby VJ. J Med Chem; 1989 Dec 04; 32(12):2555-61. PubMed ID: 2555512 [Abstract] [Full Text] [Related]
12. Cysteine residues are involved in structure and function of melanocortin 1 receptor: Substitution of a cysteine residue in transmembrane segment two converts an agonist to antagonist. Frändberg PA, Doufexis M, Kapas S, Chhajlani V. Biochem Biophys Res Commun; 2001 Mar 09; 281(4):851-7. PubMed ID: 11237737 [Abstract] [Full Text] [Related]
14. Topographical modification of melanotropin peptide analogues with beta-methyltryptophan isomers at position 9 leads to differential potencies and prolonged biological activities. Haskell-Luevano C, Boteju LW, Miwa H, Dickinson C, Gantz I, Yamada T, Hadley ME, Hruby VJ. J Med Chem; 1995 Nov 10; 38(23):4720-9. PubMed ID: 7473600 [Abstract] [Full Text] [Related]
15. Design of novel chimeric melanotropin-deltorphin analogues. Discovery of the first potent human melanocortin 1 receptor antagonist. Han G, Quillan JM, Carlson K, Sadée W, Hruby VJ. J Med Chem; 2003 Feb 27; 46(5):810-9. PubMed ID: 12593660 [Abstract] [Full Text] [Related]
16. Comparative biological activities of potent analogues of alpha-melanotropin. Effect of nonaromatic and para substituted aromatic amino acids at position 7. Wilkes BC, Cody WL, Hruby VJ, Castrucci AM, Hadley ME. Int J Pept Protein Res; 1986 Jun 27; 27(6):685-94. PubMed ID: 3489682 [Abstract] [Full Text] [Related]